0001144204-14-000871.txt : 20140107 0001144204-14-000871.hdr.sgml : 20140107 20140107061557 ACCESSION NUMBER: 0001144204-14-000871 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140107 DATE AS OF CHANGE: 20140107 EFFECTIVENESS DATE: 20140107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INNOVUS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001411879 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870324697 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-209397 FILM NUMBER: 14512024 BUSINESS ADDRESS: STREET 1: 4275 EXECUTIVE SQUARE, SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-964-5123 MAIL ADDRESS: STREET 1: 4275 EXECUTIVE SQUARE, SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: North Horizon, Inc. DATE OF NAME CHANGE: 20070910 D 1 primary_doc.xml X0707 D LIVE 0001411879 INNOVUS PHARMACEUTICALS, INC. 4275 EXECUTIVE SQUARE, SUITE 200 LA JOLLA CA CALIFORNIA 92037 858-964-5123 NEVADA None North Horizon, Inc. Corporation true Bassam Damaj 4275 Executive Square, Suite 200 La Jolla CA CALIFORNIA 92037 Executive Officer Director Vivian Liu 4275 Executive Square, Suite 200 La Jolla CA CALIFORNIA 92037 Director Henry Esber 4275 Executive Square, Suite 200 La Jolla CA CALIFORNIA 92037 Director Ziad Mirza 4275 Executive Square, Suite 200 La Jolla CA CALIFORNIA 92037 Director Pharmaceuticals $1 - $1,000,000 06b false 2013-12-24 false true true Securities exchanged for securities of Semprae Laboratories, Inc. ("Semprae") 3,201,776 shares of Issuer's common stock were issued in exchange for all of the issued and outstanding shares of common stock held by 28 stockholders of Semprae. 0 Indefinite 0 Indefinite See Item 10 false 28 0 0 0 false INNOVUS PHARMACEUTICALS, INC. /s/ Bassam Damaj Bassam Damaj President and Chief Executive Officer 2014-01-07